Does elevated zonulin increase intestinal permeability?

Zonulin, the precursor to haptoglobin 2, is currently the only known physiological protein capable of modulating intestinal permeability by reversible regulation of intercellular tight junctions. Research identifies it as a primary driver of barrier dysfunction, often referred to as "leaky gut," particularly in response to triggers like gluten or certain gut bacteria.

Mechanistic pathways

The association between elevated zonulin and permeability is rooted in a specific intracellular signaling cascade:

• Receptor Activation: Zonulin binds to the epidermal growth factor receptor (EGFR) and proteinase-activated receptor 2 (PAR2) on the surface of intestinal epithelial cells.
• Cytoskeletal Reorganization: This binding activates protein kinase C (PKC-α), which triggers the phosphorylation of tight junction proteins.
• Protein Displacement: The signaling leads to the reorganization of the actin cytoskeleton and the displacement of key scaffolding proteins, specifically zonula occludens-1 (ZO-1) and occludin, from the tight junction complex.
• Barrier Opening: As these proteins detach, the paracellular space between cells widens, allowing for the translocation of luminal antigens and pathogens into the bloodstream.

Clinical evidence and considerations

While the biological mechanism is well-defined, the application of zonulin as a clinical biomarker presents certain complexities:

• Diagnostic Utility: Elevated serum and fecal zonulin levels are frequently observed in patients with conditions characterized by impaired barrier function, such as Celiac disease, Type 1 diabetes, and Irritable Bowel Syndrome (IBS).
• Correlation with Gold Standards: Some studies show a significant correlation between serum zonulin and the lactulose/mannitol (L/M) ratio—the gold standard for measuring permeability. However, this correlation is not universal across all study populations, leading to discussions regarding the timing of measurement and the transient nature of zonulin release.
• Assay Specificity: Researchers have noted that some commercial ELISA kits used to measure zonulin may cross-react with other proteins, such as properdin or complement factor H, which can complicate the interpretation of results in a clinical setting.

Bottom line

The claim that elevated zonulin is associated with increased intestinal permeability is strongly supported by mechanistic science. Zonulin directly initiates the disassembly of tight junction proteins (ZO-1 and occludin), leading to a measurable increase in paracellular transport. While the physiological pathway is robust, clinical testing should be interpreted with caution due to potential assay variability and the transient nature of protein expression.